Success Story Nuance Communications, Inc. (NASDAQ: NUAN), recently announced a success story at Einstein Healthcare in Philadelphia, where VIDA's LungPrint Discovery was deployed through the Nuance AI Marketplace, into PowerScribe™ One. Einstein Healthcare has already processed nearly 1,400 studies using LungPrint Discovery to address the diagnostic challenges of the COVID-19
A Discussion Between Thoracic Radiologist John Newell, MD, and VIDA CEO Susan Wood, PhD On May 1, 2020, during AuntMinnie's 2020 Virtual Conference, Dr. Newell and Dr. Wood discussed the evolving role of imaging for COVID-19 and the importance of a holistic, quantitative approach to managing patients with respiratory conditions.
Coralville, IA (October 14, 2019) — VIDA Diagnostics, Inc. (“VIDA”), the leader in AI-powered lung imaging analysis, announced a distribution agreement with TeraRecon, Inc., a leader in advanced visualization, artificial intelligence, image viewing, and post-processing. With this agreement, VIDA’s LungPrint® analysis will be available through TeraRecon’s AI Interoperability platform, EnvoyAI, expanding
Our CEO, Susan Wood, was recently interviewed by the Nuance team about LungPrint and the AI market in general. See the full interview on the What's Next Blog by Nuance. Click Here to Read More -end-
CORALVILLE, Iowa, June 25, 2019 /PRNewswire/ -- VIDA Diagnostics, Inc. ("VIDA"), the leader in pulmonary imaging analytics, today announced it has joined the Nuance AI Marketplace for Diagnostic Imaging as a technology partner. With this agreement, VIDA's LungPrint® Discovery analysis will be available through the Nuance AI Marketplace to 70 percent of all radiologists across
Marcel Nienhuis Pulmonology Clinician Needs When speaking with clinicians (e.g. pulmonologists), we often ask “what kind of relationship do you have with your radiology department?” The most common answer goes something like this: “It’s OK. They give me a general report that provides some help, but I wish I could
